注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
代码 | 交易平台 | 货币 | ||
---|---|---|---|---|
GILD | 纳斯达克 | USD | 实时 | |
0QYQ | 伦敦 | USD | 实时 | |
GILD | 墨西哥 | MXN | 延迟 | |
GGILD | 米兰 | EUR | 实时 | |
GILD | 法兰克福 | EUR | 延迟 | |
GILD | 德国法兰克福 | EUR | 延迟 | |
GILD | TradeGate | EUR | 延迟 | |
GILDm | 阿根廷 | ARS | 延迟 | |
GILD34 | B3 | BRL | 延迟 | |
GILD | 奥地利维也纳 | EUR | 实时 | |
GILD | 秘鲁利马 | USD | 延迟 |
Gilead Sciences Inc是一家生物制药公司。该公司专注于预防和治疗人类免疫缺陷病毒(HIV)、病毒性肝炎和癌症等疾病的药物的发现、开发和商业化。该公司针对HIV/AIDS患者的产品包括 Biktarvy、Genvoya、Descovy、Odefsey、Truvada、Complera/Eviplera和Stribild。该公司的COVID-19产品是 Veklury 。该公司还提供用于肝病的Epclusa、Harvoni、Vemlidy和Viread产品。血液/肿瘤/细胞疗法下的产品包括Yescarta、Tecartus、Trodelvy和Zydelig。该公司的其他产品包括Letairis(安立生坦)、Ranexa(雷诺嗪)、Cayston、Jyseleca和AmBisome(注射用两性霉素 B 脂质体)。该公司还在美国销售和分销Epclusa和Harvoni的仿制药。该公司还专注于通过针对免疫抑制受体的激动剂恢复免疫平衡。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Daniel P. O'Day | 57 | 2019 | Chairman & CEO |
Paul Berg | 97 | 1998 | Member of Scientific Advisory Board |
Grace E. Colon | 56 | 2023 | Chairman of the Board |
Joel R. Huff | - | - | Chairperson of Scientific Advisory Board |
Kelly A. Kramer | 56 | 2016 | Independent Director |
Javier J. Rodriguez | 53 | 2020 | Independent Director |
Sandra J. Horning | 75 | 2020 | Independent Director |
Jeffrey A. Bluestone | 71 | 2020 | Independent Director |
Ted W. Love | 65 | 2024 | Independent Director |
Jacqueline K. Barton | 71 | 1989 | Independent Director |
Eugene R. Schiff | - | - | Member of the Scientific Advisory Board |
John W. Mellors | 86 | - | Member of the Scientific Advisory Board |
Harish M. Manwani | 71 | 2018 | Independent Director |
Eric J. Topol | 70 | - | Member of Scientific Advisory Board |
Robert A. Harrington | 63 | - | Member of the Scientific Advisory Board |
Paul E. Klotman | - | - | Member of the Scientific Advisory Board |
Francis V. Chisari | - | - | Member of the Scientific Advisory Board |
Robert T. Schooley | - | - | Member of the Scientific Advisory Board |
Nezam H. Afdhal | 67 | - | Member of Scientific Advisory Board |
Mark C. Genovese | - | - | Member of Scientific Advisory Board |
Malcolm MacCoss | 76 | - | Member of Scientific Advisory Board |
Anthony Welters | 69 | 2020 | Lead Independent Director |
Kenneth C. Anderson | 73 | - | Member of the Scientific Advisory Board |
Brian J. Druker | 68 | - | Member of the Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核